Processa set to join russell microcap® index

Hanover, md, june 08, 2021 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), (“processa” or the “company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, is set to join the russell microcap® index at the conclusion of the 2021 russell indexes annual reconstitution effect after the us market opens on june 28, according to a preliminary list of additions posted june 4.
PCSA Ratings Summary
PCSA Quant Ranking